The impact of IV connectors on clinical practice and patient outcomes

JAVA - Journal of the Association for Vascular Access

Volumn 15, Issue 3, 2010, Pages 126-127

  Macklin, Denise ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; HEPARIN;

BACTERIUM CONTAMINATION; BIOFILM; CARDIOVASCULAR EQUIPMENT; CATHETER INFECTION; CLINICAL PRACTICE; DEVICE; FLUSHING; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTRAVENOUS CONNECTOR; MICROBIAL ADHESION; NEEDLENESS MECHANICAL VALVE; POSITIVE PRESSURE MECHANICAL VALVE; REVIEW;

EID: 79952331378     PISSN: 15528855     EISSN: 15571289     Source Type: Journal    
DOI: 10.2309/java.15-3-4     Document Type: Article

References (31)

1. Arduino, M. J., Bland, L. A., Danzig, L.E., McAllister, S. K., Aquero, S. M. (1997) Microbiologic evaluation of needleless and needle-access devices. American Journal of Infection Control, 25, 377-360.
2. Bouza, E., Muoz, P., Lopez-Rodriguez, J., Perez, M. J., Rincon C, Rabadan, P. M., et.al. (2003) A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. Journal of Hospital Infection, 54, 279-287.
3. Bucki, B., Tomaszewska, R., Karpe, J., Stoksik, P., Soñta- Jakimczyk, D., Szczepañski, T. (2008) Central venous access ports in children treated for hematopoietic malignancies. Pediatric Hematology & Oncolog, 25(8), 751-5.
4. Chernecky C. (2010) Comparison of Bacterial CFUs in 5 Intravenous Connectors. Clinical Nursing Research, doi: 10.1177/1054773810375110.
5. Chernecky C., Casella L., Jarvis E., Macklin, D., Rosenkoetter., M. (2009) Nurse' knowledge of intravenous connectors. Journal of Research in Nursing, doi: 10.1177/1744987109351865.
6. Cook, G., Meyer, T., Luchsinger, B. (2007) Luer Activated Device Priming Volume As a predictor of biofilm formation in an in vitros assay. http://www.rymedtech.com/assets/files/clinical-info/Bacterin%20- %20Guy%20Cook%20Poster%20050509.pdf
7. nd ed. Washington D.C.: Association for Professionals in Infection Control and Epidemiology, 24(1)1-24, 26.
8. Dal, M.A., Guerretta, L., Mazzufero, F., Rasero, L. (2009) The management of totally implanted venous ports in the ambulatory oncologic patient. Journal of Vascular Access, 10(1), 22-6.
9. Dillon, P. W., Jones, G. R., Bagnall-Reeb, H. A., Buckley, J.D., Wiener, E. S., Haase, G. M. (2004) Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study. Journal of Clinical Oncology, 22(13), 2718-23. (Pubitemid 41103760)
10. Donlan RM, Costerton JW. (2002) Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clinical Microbiology Reviews. 15(2), 167-193. (Pubitemid 34303762)
11. Edmiston, C. E., Markina, V. (2010) Reducing the risk of infection in vascular access patients: An in vitro evaluation of an antimicrobial silver nanotechnology luer activated device. Journal of Infection Control, 1-3 doi 10.1016/jajic.2009.09.010.
12. Field, K., McFarlane, C., Cheng, A., Hughes, A. J., Jacobs, D. et. al. (2007) Incidence of catheter-related bloodstream infection among patients with needleless mechanical valve-based intravenous connector in an Australian Hematology-Oncology Unit. Infection Control and Hospital Epidemiology, 28(5), 610-613.
13. Garland, J. S., Alex, C. P., Sevallius, J. M., Murphy, D.M., Good, M. J., Volberding, A. M., et.al. (2008) Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infection Control and Hospital Epidemiology, 29(3), 243-249.
14. Harnage, S. A. (2007) Achieving Zero Catheter Related Blood Stream Infections: 15 Months Success in a Community Based Medical Center. Journal of the Association for Vascular Access, 12(4), 218-24.
15. Jacobs, B. R. (2003) Central venous catheter occlusion and thrombosis. Critical Care Clinics, 19(3), 489-514.
16. Jarvis, W. R., Murphy, C., Hall, K. K., Fogle, P. J., Karchmer, T. B., Harrington G, et.al. (2009) Health care-associated blood-stream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. Clinical Infectious Diseases, 49(12), 1821-1827.
17. Kuhle, S., Koloshuk, B., Marzinotto, V., Bauman, M., Massicotte, P., Andrew, M., et.al. (2003) A cross-sectional study evaluating post-thrombotic syndrome in children. Thrombosis Research, 111(4-5), 227-33.
18. Maki, D. G. (2010) In Vitro Studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection. Clinical Infectious Diseases, 50(12), 1580-1587.
19. Maragakis, L. L., Bradley, K. L., Song, X., Beers, C., Miller, M. R., Cosgrove, S. E., Perl, T.M. (2006) Increased catheterrelated valve intravenous access port. Infection Control and Hospital Epidemiology, 27(1),67-70.
20. Marschall, J., Mermel, L. A., Classen, D., Arias, K. M., Podgorny, K., Anderson, D. J., et. al. (2008) Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infection Control and Hospital Epidemiology, 29, S22-S30.
21. Menyhay, S. Z., Maki, D. G. (2006) Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap. Infection Control and Hospital Epidemiology, 27(1), 3-7.
22. Murga, R., Miller, M., Donlan, R. M. (2001) Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. Journal of Clinical Microbiology, 39(6), 2294-2297 (Pubitemid 32531498)
23. Nelson Laboratories , Inc., Salt Lake City, UT 2007 lab # 395445 & 398575
24. Nelson Laboratories , Inc., Salt Lake City, UT 2009 lab # 458652
25. Ociepa, T., Maloney, E., Urasinski, T., Sawicki, M. (2010)Thrombotic complications of tunneled central lines in children with malignancy. Journal of Pediatric Hematology/Oncology, 32(2), 88-92
26. Radd, I. (1998) Intravascular-catheter-related infections. Lancet, 351, 893-893.
27. Rupp, M. E., Sholtz, L. A., Jourdan, D. R., Marion, N. D., Tyner, L. K., Fey, P. D., et.al. (2007) Outbreak of blood-stream infection temporally associated with the use of an intravascular needleless valve. Clinical Infectious Diseases, 44(11), 1408-1414.
28. Safdar, N., Maki, D. G. (2004) The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med, 30, 62-67. (Pubitemid 38147108)
29. Seymour, V. M., Dhallu, T. S., Moss, H.A., Tebbs, S. E., Elliot, T. S. (2000) A prospective clinical study to investigate the microbial contamination of a needleless connector. Journal of Hospital Infection, 45(2), 165-8.
30. Salgado, C., Chinnes, L., Paczesny, T., Cantey, R., (2007) Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infection Control and Hospital Epidemiology, 28(6),684-688. (Pubitemid 46954754)
31. van Rooden, C. J., Schippers, E. F., Guiot, H. F., Barge, R. M., Hovens, M. M., van der Meer, F. J., et.al. (2008) Prevention of Coagulase-negative Staphylococal Central Venous Cahteter-related Infection Using Urokinase Rinses: A randomized Double-Blind Controlled Trial in Patients with Hematologic Malignancies. Journal of Clinical Oncology, 20:428-433.